Retina/Vitreous News

The Sing IMT improved distance and near vision at 6 months in patients with late-stage age-related macular degeneration, with minimal impact on the corneal endothelium, according to a study published in Heliyon.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Baruch D. Kuppermann, MD, PhD, and Rishi P. Singh, MD, current and past presidents of Retina World Congress, preview this year’s meeting.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Ashkan M. Abbey, MD, discusses 1-year results from the phase 2 DAVIO 2 clinical trial investigating EYP-1901 in previously treated wet age-related macular degeneration.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, W. Lloyd Clark, MD, discusses positive results from three clinical trials investigating NT-501 for macular telangiectasia type 2.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Allen C. Ho, MD, discusses the growing promise of optogenetic therapy in treating patients with retinal disease.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Hawaiian Eye meeting with guests Paul Singh, MD, Candy Simerson, Jeffrey Goldberg, MD, PhD, and Roger Goldberg, MD, MBA.

Duravyu at two dose levels met its primary endpoint in the treatment of diabetic macular edema in a phase 2 clinical trial, according to a press release from EyePoint Pharmaceuticals.

The FDA has granted 510(k) clearance to AI Optics’ Sentinel Camera, a handheld retinal imaging system that captures high-quality images without the need for dilation, according to a press release.

The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release.